Skip to main content
. 2009 Oct 26;54(1):360–366. doi: 10.1128/AAC.00771-09

TABLE 3.

Model building, final parameter estimates, and bootstrap results from the AZI population pharmacokinetic modeling

Parametera Value
Base model Final covariate model Bootstrap (n = 1,000) (median [95% CI])
OFV 7,999.870 7,993.646 7,974.699 [7,756.673-8,201.238]
Pharmacokinetic (estimate [% RSE])
    DUR (h) 1.66 [10.4] 1.55 [3.3] 1.56 [1.21-2.01]
    ka (h−1) 0.513 [3.2] 0.525 [14.8] 0.524 [0.451-0.623]
    VC/F (liters) 504 [13.9] 384 [17.6] 371 [235-554]
    Pregnancy on VC/F (liters) 330 [69.4] 318 [48-604]
    CL/F (liters h−1) 158 [3.9] 158 [6.7] 158 [145-171]
    VP1/F (liters) 4,080 [8.6] 4,080 [12.5] 4,045 [3,402-4,870]
    Q1/F (liters h−1) 327 [5.7] 325 [12.7] 326 [288-368]
    VP2/F (liters) 5,070 [5.6] 5,040 [7.3] 5,070 [4,262-5,730]
    Q2/F (liters h−1) 67.2 [11.5] 66.4 [12.4] 67.5 [48.5-84.0]
Random (CV % [% RSE])
BSV Vc/F 111.4 [20.9] 99.6 [35.5] 99.0 [72.6-127.6]
BSV CL/F 28.3 [24.1] 28.3 [33.1] 27.9 [21.6-34.5]
BSV VP1/F 35.8 [27.0] 35.6 [27.2] 34.8 [25.7-45.2]
BSV DUR 73.0 [21.4] 76.9 [22] 75.5 [55.4-95.6]
RUV
Proportional error (CV % [% RSE]) 31.3 [9.5] 31.2 [15.1] 30.9 [28.1-33.8]
a

CV, coefficient of variation.